Internal Medicine, Pulmonary Disease · Plymouth, MA
NPI
1215927991
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
116 Court St Ste 1
Plymouth, MA, 02360
Phone (508) 747-1318
Groups this clinician bills Medicare through
Medicare paid, 2024
$137K
2,815 services
Medicare patients, 2024
719
Average age 76
Drug cost, 2024
$1.2M
6,559 prescriptions
Company payments, 2025
$101
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John M Wengryn was code 99214 (office e&m - established), 430 times for 226 patients. In total John M Wengryn billed 2,815 services in 47 codes, and Medicare paid $137K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 430 | 226 | $97.38 | $42K |
| 99213 Office E&M - Established | Office | 413 | 238 | $61.13 | $25K |
| 99232 Hospital E&M - Subsequent | Facility | 279 | 102 | $61.02 | $17K |
| 94729 Pulmonary Function Testing | Facility | 248 | 245 | $6.67 | $1,653 |
| 94726 Pulmonary Function Testing | Facility | 235 | 232 | $8.93 | $2,098 |
| 94010 Pulmonary Function Testing | Facility | 154 | 152 | $6.15 | $947 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 145 | 145 | $131.02 | $19K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 143 | 143 | $19.32 | $2,762 |
| 99231 Hospital E&M - Subsequent | Facility | 117 | 35 | $37.50 | $4,387 |
| 96372 Injection Administration | Office | 103 | 15 | $8.10 | $834 |
| 94060 Pulmonary Function Testing | Facility | 95 | 94 | $7.70 | $731 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 79 | 12 | $0.76 | $60.29 |
| 99238 Hospital Discharge Management | Facility | 57 | 39 | $62.20 | $3,546 |
| 94010 Pulmonary Function Testing | Office | 37 | 34 | $19.63 | $726 |
| 99223 Hospital E&M - Initial | Facility | 35 | 34 | $133.98 | $4,689 |
By year: 2022 $117K for 2,472 services; 2023 $136K for 2,917 services; 2024 $137K for 2,815 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 32 | 23 | $3.41 | $109 |
Medicare prescription drug claims, 2024
In 2024, the drug John M Wengryn prescribed most often to Medicare patients was Metoprolol Succinate, with 296 prescriptions and refills. In total John M Wengryn wrote 6,559 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 296 | 727 | 70 | $4,970 |
| Losartan Potassium Generic | 248 | 642 | 61 | $2,494 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 208 | 298 | 36 | $180K |
| Levothyroxine Sodium Generic | 202 | 574 | 52 | $1,524 |
| Atorvastatin Calcium Generic | 185 | 522 | 59 | $2,740 |
| Prednisone Generic | 171 | 235 | 44 | $1,455 |
| Amlodipine Besylate Generic | 164 | 400 | 37 | $838 |
| Eliquis Apixaban | 162 | 248 | 28 | $138K |
| Furosemide Generic | 149 | 304 | 38 | $731 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 147 | 176 | 46 | $4,610 |
| Lisinopril Generic | 146 | 400 | 35 | $786 |
| Omeprazole Generic | 140 | 419 | 42 | $2,753 |
| Azithromycin Generic | 130 | 250 | 32 | $3,313 |
| Trazodone Hcl Generic | 110 | 212 | 23 | $722 |
| Escitalopram Oxalate Generic | 108 | 197 | 19 | $1,350 |
Brand drugs: 1,384 claims; generic drugs: 5,156 claims; opioid claims: 88.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John M Wengryn $101 ($101 in general payments such as food, travel and fees) from 2 companies. The largest payer was Galvanize Therapeutics, Inc with $71.87.
| Company | Payments | Amount |
|---|---|---|
| Galvanize Therapeutics, Inc | 1 | $71.87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.